Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations
about
A mouse model for Costello syndrome reveals an Ang II-mediated hypertensive conditionNoonan syndromeA restricted spectrum of NRAS mutations causes Noonan syndromeBRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitorsOncogenic RIT1 mutations in lung adenocarcinoma.Current management of juvenile myelomonocytic leukemia and the impact of RAS mutationsA graph theoretic approach to utilizing protein structure to identify non-random somatic mutations.Ras and Rap signaling in synaptic plasticity and mental disorders.Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrumNoonan syndrome: clinical aspects and molecular pathogenesis.Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndromeKRAS and BRAF mutational status in colon cancer from Albanian patients.Disorders of dysregulated signal traffic through the RAS-MAPK pathway: phenotypic spectrum and molecular mechanismsMEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutationNoonan syndrome and clinically related disorders.Cardio-facio-cutaneous syndrome: does genotype predict phenotype?SOS1 mutations in Noonan syndrome: molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlationsCancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromesOncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site.KRAS G12D mosaic mutation in a Chinese linear nevus sebaceous syndrome infant.Activated Kras alters epidermal homeostasis of mouse skin, resulting in redundant skin and defective hair cycling.Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutantsKRAS mutations and subtyping in colorectal cancer in Jordanian patients.Genetics of Bladder Malignant Tumors in ChildhoodAn unexpected new role of mutant Ras: perturbation of human embryonic developmentDe novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype-phenotype relationships and overlap with Costello syndrome.Adults with genetic syndromes and cardiovascular abnormalities: clinical history and management.Noonan, Costello and cardio-facio-cutaneous syndromes: dysregulation of the Ras-MAPK pathway.Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).Ras/MAPK syndromes and childhood hemato-oncological diseases.Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling in humans and mice.Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes.Genotype and phenotype spectrum of NRAS germline variants.De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders.Negative regulation of Shh levels by Kras and Fgfr2 during hair follicle developmentNRAS Mutations in Noonan Syndrome.An atypical case of Noonan syndrome with KRAS mutation diagnosed by targeted exome sequencing
P2860
Q24655745-16DA8D48-D371-4184-99BB-51121656934EQ27001641-6963D86D-9AFF-4115-B626-317A7083AD6AQ27658480-1B62E0D2-0DED-484D-A4C2-725AC7444C0CQ27851843-2BF41F95-6979-4FE3-980E-689E7418755EQ27852800-77491425-9FC6-41C6-B6F2-AA7807B2FCBFQ28263773-07E6F2BD-2C4E-4175-9A19-360D1BACE68FQ30360645-6E0AE252-3E7B-4114-8849-E2A1BE4325B2Q30431817-EE6C6DED-B969-431F-B674-2A269C9328C3Q33637874-0F1AB1DC-1467-4BC4-BCD4-E1B0BEAA99FAQ33806161-B58DC12C-7178-441E-B4EA-DB6910764A15Q34263083-70AC75AC-F98C-46E1-A1FD-8FB0433586C1Q34326050-1D618E2E-EB07-4111-98D7-4B9194559C5EQ34346064-B1724818-4580-4BD9-B686-2E97C480AB03Q34440570-DD8B29AA-67F4-4141-98EE-104966F4FC53Q34627221-8E9FACF2-AFCD-4935-9D3D-64D0D8D3F6D8Q34678373-527268B3-B23A-48E2-962D-633651D0C90EQ34906349-87BDE296-4988-49BC-9387-3D9EFD9E5427Q35056507-6043A4A6-6C33-430F-B682-7354698F624CQ35475470-4457D6B9-3DE0-4CD2-A6FA-D97FCFEFF238Q35669207-21B93731-4D13-4CD4-9199-33B5744ACEEBQ35828637-7571E9C8-86DC-4C9C-830E-AC2124DF830AQ35910748-2AA99DF4-3493-4A01-8038-83C57B52CA54Q36277286-5F287F80-76D2-47EE-8951-BE38B81164E9Q36424058-DEFF8F0D-A29E-44A1-93F6-1066FA5C2907Q36658484-32A85A63-5E90-4F06-9829-30D862FAA9E3Q36702801-DF377011-E929-4ADE-8CC3-5D755FF61679Q37004691-9EA73108-905A-4284-86B0-FB0FC010CF6DQ37121001-169BE5F4-60AD-4EBD-9834-7A1F72E1CEF3Q37164120-9793943E-C809-438F-884D-8B87B9792291Q37343475-5B32DC78-EEC9-4D2D-B498-3C8B923135D6Q37418909-C4B0887F-64B5-4050-A21E-31D4D19143ACQ38068387-4F5C3687-E409-4AEC-A405-1BB3679F3C93Q38271699-DBBED492-A898-4036-960F-8B94F0327F93Q39260997-263E43B0-6D18-45FF-AB5C-0A358CCA7F60Q40180317-715F6C3B-AC0D-460F-BBEC-CB4D5AA813A0Q41774745-1BB407D4-A379-425E-8FBD-D4C081266400Q42049635-2D9C8FA8-8CB8-4645-9883-C4066309101FQ42136008-73725B5D-F1E0-4330-8213-D0D74E537FE8Q42215601-4C8219CE-EB7D-4D36-B047-62C005FAED7FQ42378183-29FDC977-B8EE-4F10-BAEA-DCF7E305073C
P2860
Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutations
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 October 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expansion of the genotypic and ...... s with KRAS germline mutations
@en
Expansion of the genotypic and ...... with KRAS germline mutations.
@nl
type
label
Expansion of the genotypic and ...... s with KRAS germline mutations
@en
Expansion of the genotypic and ...... with KRAS germline mutations.
@nl
prefLabel
Expansion of the genotypic and ...... s with KRAS germline mutations
@en
Expansion of the genotypic and ...... with KRAS germline mutations.
@nl
P2093
P2860
P50
P356
P1476
Expansion of the genotypic and ...... s with KRAS germline mutations
@en
P2093
Anna Leana Schulz
Anne S Quante
Christian P Kratz
Dagmar Hansmann
Denise Horn
Dirk Schnabel
Helmut Barth
Katarina Lehmann
Lars-Erik Wehner
Martina Kreiss-Nachtsheim
P2860
P304
P356
10.1136/JMG.2006.046300
P407
P577
2006-10-20T00:00:00Z